Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Zoetis Services identifies IL-1beta, IL-6 and TNF-alpha production inhibitors

Oct. 7, 2021

Elastase inhibition enhances the adjuvant activity of alum for SARS-CoV-2 vaccination

Oct. 1, 2021

Recombinant hemagglutinin-expressing HSV vector offers protection against both HSV and influenza

Oct. 1, 2021

Characterization of potent and selective inhibitors of BET BD2

Sep. 23, 2021

SQZ announces celiac disease as first autoimmune clinical translation of TAC platform

Sep. 14, 2021

Impact BioMedical reports synthesis of first Quantum-based compound

Sep. 8, 2021

Amilo-5MER shows efficacy in animal models of SAA-associated pathologies

Sep. 8, 2021

Celsion reports in vivo data on PLACCINE DNA vaccine platform against SARS-CoV-2

Sep. 3, 2021

Brickell licenses rights to Voronoi's DYRK1A inhibitors

Sep. 2, 2021

Discovery of CPL-302415 as promising preclinical candidate for SLE

Sep. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...